Slideshow

Obesity Management: ENDO 2017 Highlights

Author(s):

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Three highlights of obesity research examined the impact of corticosteroid use on prevalence of metabolic syndrome, explored the effects of a weight management program on job performance, and investigated the consequences of Vitamin D deficiency in overweight and obese children and adolescents.

Related Videos
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
© 2024 MJH Life Sciences

All rights reserved.